These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22244026)

  • 1. Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogenetics.
    Calarge CA; Ellingrod VL; Zimmerman B; Bliziotes MM; Schlechte JA
    J Clin Psychiatry; 2011 Dec; 72(12):1685-90. PubMed ID: 22244026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys.
    Calarge CA; Zimmerman B; Xie D; Kuperman S; Schlechte JA
    J Clin Psychiatry; 2010 Mar; 71(3):338-47. PubMed ID: 20331935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the serotonin transporter-linked polymorphic region genotype with lower bone mineral density.
    Lapid MI; Kung S; Frye MA; Biernacka JM; Geske JR; Drake MT; Jankowski MD; Clarke BL
    Transl Psychiatry; 2017 Aug; 7(8):e1213. PubMed ID: 28892067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal examination of the skeletal effects of selective serotonin reuptake inhibitors and risperidone in boys.
    Calarge CA; Burns TL; Schlechte JA; Zemel BS
    J Clin Psychiatry; 2015 May; 76(5):607-13. PubMed ID: 26035190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study.
    Feuer AJ; Demmer RT; Thai A; Vogiatzi MG
    Bone; 2015 Sep; 78():28-33. PubMed ID: 25940460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining Whether Genetic Variants Moderate the Skeletal Effects of Selective Serotonin Reuptake Inhibitors in Older Adolescents and Young Adults.
    Ezenwabachili I; Deumic Shultz E; Mills JA; Ellingrod V; Calarge CA
    J Child Adolesc Psychopharmacol; 2023 Sep; 33(7):260-268. PubMed ID: 37579130
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.
    Haney EM; Chan BK; Diem SJ; Ensrud KE; Cauley JA; Barrett-Connor E; Orwoll E; Bliziotes MM;
    Arch Intern Med; 2007 Jun; 167(12):1246-51. PubMed ID: 17592097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium and Vitamin D Supplementation in Boys with Risperidone-Induced Hyperprolactinemia: A Randomized, Placebo-Controlled Pilot Study.
    Calarge CA; Mills JA; Ziegler EE; Schlechte JA
    J Child Adolesc Psychopharmacol; 2018 Mar; 28(2):145-150. PubMed ID: 29112461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.
    Zhou C; Fang L; Chen Y; Zhong J; Wang H; Xie P
    Osteoporos Int; 2018 Jun; 29(6):1243-1251. PubMed ID: 29435621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms.
    Dombrovski AY; Mulsant BH; Ferrell RE; Lotrich FE; Rosen JI; Wallace M; Houck PR; Mazumdar S; Pollock BG
    Int Clin Psychopharmacol; 2010 Jan; 25(1):37-45. PubMed ID: 19996755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Serotonin Reuptake Inhibitors Reduce Longitudinal Growth in Risperidone-Treated Boys.
    Calarge CA; Mills JA; Karaviti L; Teixeira AL; Zemel BS; Garcia JM
    J Pediatr; 2018 Oct; 201():245-251. PubMed ID: 29958671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effect of selective serotonin reuptake inhibitors on bone mineral density: an observational cross-sectional study.
    Ak E; Bulut SD; Bulut S; Akdağ HA; Öter GB; Kaya H; Kaya OB; Şengül CB; Kısa C
    Osteoporos Int; 2015 Jan; 26(1):273-9. PubMed ID: 25187118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal Bone Microstructure and Density But Worse Physical Function in Older Women Treated with Selective Serotonin Reuptake Inhibitors, a Cross-Sectional Population-Based Study.
    Larsson B; Mellström D; Johansson L; Nilsson AG; Lorentzon M; Sundh D
    Calcif Tissue Int; 2018 Sep; 103(3):278-288. PubMed ID: 29730704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density in male adolescents with autism spectrum disorders and disruptive behavior disorder with or without antipsychotic treatment.
    Roke Y; van Harten PN; Buitelaar JK; Tenback DE; Quekel LG; de Rijke YB; Boot AM
    Eur J Endocrinol; 2012 Dec; 167(6):855-63. PubMed ID: 23011870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients.
    Smits KM; Smits LJ; Peeters FP; Schouten JS; Janssen RG; Smeets HJ; van Os J; Prins MH
    Psychiatr Genet; 2008 Aug; 18(4):184-90. PubMed ID: 18628680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Selective Serotonin Reuptake Inhibitors and Bone Mineral Density in Elderly Women.
    Saraykar S; John V; Cao B; Hnatow M; Ambrose CG; Rianon N
    J Clin Densitom; 2018; 21(2):193-199. PubMed ID: 28712980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin Transporter Gene Polymorphisms and Selective Serotonin Reuptake Inhibitor Tolerability: Review of Pharmacogenetic Evidence.
    Zhu J; Klein-Fedyshin M; Stevenson JM
    Pharmacotherapy; 2017 Sep; 37(9):1089-1104. PubMed ID: 28654193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serotonin transporter promoter polymorphism (5-HTTLPR) affects the relation between antidepressant serum concentrations and effectiveness in major depression.
    Dreimüller N; Tadić A; Dragicevic A; Boland K; Bondy B; Lieb K; Laux G; Maier W; Müller MJ; Rao ML; Rietschel M; Röschke J; Zill P; Hiemke C
    Pharmacopsychiatry; 2012 May; 45(3):108-13. PubMed ID: 22086748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Depression, Generalized Anxiety, and Selective Serotonin Reuptake Inhibitors on Change in Bone Metabolism in Adolescents and Emerging Adults.
    Calarge CA; Mills JA; Janz KF; Burns TL; Schlechte JA; Coryell WH; Zemel BS
    J Bone Miner Res; 2017 Dec; 32(12):2367-2374. PubMed ID: 28815738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin transporter polymorphism and bleeding time during SSRI therapy.
    Hougardy DM; Egberts TC; van der Graaf F; Brenninkmeijer VJ; Derijks LJ
    Br J Clin Pharmacol; 2008 May; 65(5):761-6. PubMed ID: 18279474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.